Cargando…

An Engineered Probiotic Produces a Type III Interferon IFNL1 and Reduces Inflammations in in vitro Inflammatory Bowel Disease Models

[Image: see text] The etiology of inflammatory bowel diseases (IBDs) frequently results in the uncontrolled inflammation of intestinal epithelial linings and the local environment. Here, we hypothesized that interferon-driven immunomodulation could promote anti-inflammatory effects. To test this hyp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chua, Koon Jiew, Ling, Hua, Hwang, In Young, Lee, Hui Ling, March, John C., Lee, Yung Seng, Chang, Matthew Wook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498420/ https://www.ncbi.nlm.nih.gov/pubmed/36399014 http://dx.doi.org/10.1021/acsbiomaterials.2c00202

Ejemplares similares

Engineering Escherichia coli for diagnosis and management of hyperuricemia
por: Gencer, Gozde, et al.
Publicado: (2023)

Engineering probiotics to inhibit Clostridioides difficile infection by dynamic regulation of intestinal metabolism
por: Koh, Elvin, et al.
Publicado: (2022)

Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models
por: Hwang, In Young, et al.
Publicado: (2017)

Hepatic Interferon-λ3 (IFNL3) Gene Expression Reveals Not to Be Attenuated in Non-Favorable IFNL3 rs4803217 or IFNL4 rs368234815 Minor Allele Carriers in Chronic Hepatitis C
por: Amanzada, Ahmad, et al.
Publicado: (2015)

Interferon-λ(4) (IFNL4) Transcript Expression in Human Liver Tissue Samples
por: Amanzada, Ahmad, et al.
Publicado: (2013)

IFNL4 and IFNL3 Associated Polymorphisms Strongly Influence the Spontaneous IFN-Alpha Receptor-1 Expression in HCV-Infected Patients
por: Bordi, Licia, et al.
Publicado: (2015)

Interferon lambda 4 (IFNL4) gene polymorphism is associated with spontaneous clearance of HCV in HIV-1 positive patients
por: Alves, Camila Fernanda da Silveira, et al.
Publicado: (2016)

Interferon-lambda (IFNL) germline variations and their significance for HCC and PDAC progression: an analysis of The Cancer Genome Atlas (TCGA) data
por: Huschka, Henriette, et al.
Publicado: (2020)

Selection on a Variant Associated with Improved Viral Clearance Drives Local, Adaptive Pseudogenization of Interferon Lambda 4 (IFNL4)
por: Key, Felix M., et al.
Publicado: (2014)

Association of IFNL3 rs12979860 and rs8099917 with Biochemical Predictors of Interferon Responsiveness in Chronic Hepatitis C Virus Infection
por: Fischer, Janett, et al.
Publicado: (2013)

IFNL4 genetic variant can predispose to COVID-19
por: Saponi-Cortes, Jose Maria R., et al.
Publicado: (2021)

Variants of IFNL4 Gene in Amazonian and Northern Brazilian Populations
por: Angelim, Carolina Cabral, et al.
Publicado: (2023)

Correction: Selection on a Variant Associated with Improved Viral Clearance Drives Local, Adaptive Pseudogenization of Interferon Lambda 4 (IFNL4)
Publicado: (2014)

IFNL3 genotype is associated with pulmonary fibrosis in patients with systemic sclerosis
por: Metwally, Mayada, et al.
Publicado: (2019)

Absence of association of IFNL3/IL28B rs 12979860 and IFNL4 ss 469415590 polymorphisms with the neurological status of HTLV-1 Afro-Caribbean subjects in Martinique.
por: Jeannin, Severine, et al.
Publicado: (2015)

Absence of association of IFNL3/IL28B rs 12979860 and IFNL4 ss 469415590 polymorphisms with the neurological status of HTLV-1 Afro-Caribbean subjects in Martinique.
por: Jeannin, Severine, et al.
Publicado: (2015)

Inflammatory Bowel Disease Therapeutics: A Focus on Probiotic Engineering
por: Mishra, Jayshree, et al.
Publicado: (2022)

COVID-19: Possible Impact of the Genetic Background in IFNL Genes on Disease Outcomes
por: Mihm, Sabine
Publicado: (2020)

Hepatic IFNL4 Gene Activation in Hepatocellular Carcinoma Patients with Regard to Etiology
por: Huschka, Henriette, et al.
Publicado: (2021)

Antiviral Effect of pIFNLs against PEDV and VSV Infection in Different Cells
por: Chen, Jing, et al.
Publicado: (2022)

CRISPR-Cas-Based Engineering of Probiotics
por: Liu, Ling, et al.
Publicado: (2023)

IFNL4 and donor selection for matched unrelated donor haematopoietic stem-cell transplantation
por: Westervelt, Peter
Publicado: (2020)

Polymorphisms near the IFNL3 Gene Associated with HCV RNA Spontaneous Clearance and Hepatocellular Carcinoma Risk
por: Lee, Mei-Hsuan, et al.
Publicado: (2015)

Detection of allele specific differences in IFNL3 (IL28B) mRNA expression
por: Knapp, Susanne, et al.
Publicado: (2014)

Donor IFNL4 Genotype Is Associated with Early Post-Transplant Fibrosis in Recipients with Hepatitis C
por: Aiken, Taylor, et al.
Publicado: (2016)

IFNL4 polymorphism as a predictor of chronic hepatitis C treatment efficiency in Ukrainian patients
por: Kucherenko, A. M., et al.
Publicado: (2016)

Intrahepatic TLR3 and IFNL3 Expressions Are Associated with Stages of Fibrosis in Chronic Hepatitis C
por: Guedes de Sá, Keyla Santos, et al.
Publicado: (2021)

Irritable Bowel Syndrome, Gut Microbiota and Probiotics
por: Lee, Beom Jae, et al.
Publicado: (2011)

Prevalence of Irritable Bowel Syndrome in Northern India
por: Chua, Andrew Seng Boon
Publicado: (2011)

Engineered probiotics
por: Ma, Junheng, et al.
Publicado: (2022)

Prevalence of IFNL3 rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C
por: Świątek-Kościelna, Bogna, et al.
Publicado: (2017)

Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis C
por: Huang, Chao-Min, et al.
Publicado: (2017)

High-risk Allele for Herpes Labialis Severity at the IFNL3/4 Locus is Associated With Vestibular Neuritis
por: Rujescu, Dan, et al.
Publicado: (2020)

IFNL4 Genotypes Predict Clearance of RNA Viruses in Rwandan Children With Upper Respiratory Tract Infections
por: Rugwizangoga, Belson, et al.
Publicado: (2019)

Gene–disease association with human IFNL locus polymorphisms extends beyond hepatitis C virus infections
por: Chinnaswamy, S
Publicado: (2016)

PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus‐related diseases
por: De Re, Valli, et al.
Publicado: (2020)

IFNL4 genotype influences the rate of HIV-1 seroconversion in men who have sex with men
por: Meza, Giovanna, et al.
Publicado: (2022)

Human herpesvirus 8 infection is associated with prostate cancer among IFNL4-ΔG carriers
por: Jenkins, Frank J., et al.
Publicado: (2022)

The Role of Genetically Engineered Probiotics for Treatment of Inflammatory Bowel Disease: A Systematic Review
por: Zhang, Tao, et al.
Publicado: (2023)

Targeted Approaches for In Situ Gut Microbiome Manipulation
por: Lee, Hui Ling, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fdcrkcih7vmb8qiu9sci2h5q04